The affected employees are mainly part of the company's research and development (R&D) department.
The move is...
You must be logged in to view the whole article.
Click here if you require signing up
GlaxoSmithKline says several board members will not stand for re-election
LoneStar Heart appoints Names Andrew Coats, Mark Maciejewski to board of directors
Gerald Storch joins Bristol-Myers Squibb's board of directors
Cleveland BioLabs shakes up management
Claude Allary to serve as special advisor to Arch Biopartners